Results 131 to 140 of about 1,494 (190)

Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease. [PDF]

Ann Hematol
Brummer C, Evert K, Keil F, Schmidt J, Grube M, Herr W, Radsak M, Mayer S.   +7 more
europepmc   +1 more source

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Int J Hematol
Yokota A, Munakata W, Kiguchi T, Ogawa Y, Hino M, Kato K, Chiba M, Kawasaki D, Wasa K, Mikasa T, Takeuchi K, Izutsu K, Suzuki R, Study Group.   +13 more
europepmc   +1 more source

Efficacy and Long-Term Remission Following Haploidentical HSCT for Therapy-Related Acute Myelomonocytic Leukemia with Plasmacytoid Dendritic Cells Post-FCR Therapy for CLL: A Case Report. [PDF]

J Clin Med
Catana AC, Mondoc LM, Vladoiu MG, Varady Z, Dobrea C, Sandu HM, Mocanu L, Olteanu A, Mera G, Teodoru M.   +9 more
europepmc   +1 more source

Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement. [PDF]

Cureus
Rahman Z, Haley A, Gandhi S, Mohamed A, Parza K, Quan JR.   +5 more
europepmc   +1 more source

First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level. [PDF]

Haematologica
Pemmaraju N, Herling M, Sweet KL, Stein AS, Vasu S, Rosenblat TL, Rizzieri DA, Papayannidis C, Wang ES, Konopleva M, Zuurman M, Tosolini A, Qazilbash M, Lane AA.   +13 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: A single centre Indian experience. [PDF]

Leuk Res Rep
Sabitha P, Goel A, Kumar S, R C, Fernandes S, Jain N, Pemmaraju N, Sharma A, Sahoo RK.   +8 more
europepmc   +1 more source

Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. [PDF]

Exp Ther Med
Lai Y, Chen X, Zhou H.
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm presenting as a scalp hematoma. [PDF]

JAAD Case Rep
Michelen-Gómez EA, Cancel-Artau K, Gerena-Maldonado CP, Jiménez-Sacarello I, Rivera-Rolón M, Sánchez-Pont JE, Martín-García RF.   +6 more
europepmc   +1 more source

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0. [PDF]

J Immunother Cancer
Shah NN, Craddock C, Gore L, Guzman ML, Jabbour E, Lovell AR, Luciani K, Majeti R, Maude SL, Perales MA, Pulsipher MA, Sallman DA, Shah BD, Stock W, Subklewe M, Tasian SK, Wood BL, Yates B, Daver N.   +18 more
europepmc   +1 more source